InvestorsHub Logo
Followers 14
Posts 3822
Boards Moderated 1
Alias Born 07/07/2002

Re: DewDiligence post# 964

Thursday, 04/09/2015 10:43:35 AM

Thursday, April 09, 2015 10:43:35 AM

Post# of 3011
From Barron's writeup with regard to Citigroup analyst -

"Werber also doesn’t see the results as a true challenge to Harvoni, as this regimen too takes 12 weeks—an extra month than Gilead’s drug—but it could be competitive with Merck’s."

I am interested in your take.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News